This finding in transgenic mice might also reflect the situation in patients, as KMT2A–MLLT1 leukemic cells in patients often express lymphoid markers and are diagnosed as ALL or mixed lineage leukemia, whereas KMT2A–MLLT3 mostly present with AML-M5 (11). This evidence concerns the gene MLLT3 and acute lymphoblastic leukemia.